2020
An Application of the Cure Model to a Cardiovascular Clinical Trial
Sevilimedu V, Ma S, Hartigan P, Kyriakides T. An Application of the Cure Model to a Cardiovascular Clinical Trial. Statistics In Biosciences 2020, 13: 402-430. DOI: 10.1007/s12561-020-09297-w.Peer-Reviewed Original ResearchMyocardial infarctionACS eventAggressive Drug Evaluation (COURAGE) trialClinical Outcomes Utilizing RevascularizationHazard of MICardiovascular clinical trialsDrug evaluation trialsCoronary syndromeClinical trialsMedical conditionsClinical practiceSurvival analysisCure modelNovel findingsRiskTrialsCured fractionEvaluation trialsRevascularizationInfarctionSyndrome
2017
2432
Huang Y, Brown S, Ma S, Kyriakides T. 2432. Journal Of Clinical And Translational Science 2017, 1: 37-37. PMCID: PMC6799711, DOI: 10.1017/cts.2017.137.Peer-Reviewed Original ResearchAdvanced HIV diseaseARV medicationsHIV diseaseVirtual phenotypeSubsequent managementARV treatment strategiesEffects of ARVHIV treatment trialsIndividual ARV drugsCD4 cell countAnti-retroviral drugsCurrent clinical practiceOpen labelSpecific ARVsStandard armARV regimenIntensive armViral loadTherapeutic optionsVital statusARV drugsTreatment trialsARV treatmentTreatment strategiesTrial randomization